FDA Okays Mauna Kea’s Updated Cellvizio Endomicroscopy System for GI Tracts

Mauna Kea Technologies has obtained FDA clearance for its updated Cellvizio endomicroscopy system for the GI and pulmonary tracts, according to a company release.

Advertisement

New features of the new Cellvizio 100 Series include improvements in endomicroscopic image acquisition and interpretation.

 

Used mainly in gastroenterology applications, Cellvizio provides real-time microscopic images of tissue inside the body.

 

Related Articles on FDA Clearances:

St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System

B. Braun Receives FDA 510(k) Clearance for New DUPLEX System Use

FDA OKs Covidien’s Parietex Optimized Composite for Hernia Repair


At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Gastroenterology continues to evolve rapidly as advances in colorectal cancer prevention, inflammatory bowel disease research, microbiome science and outpatient digestive…

Advertisement

Comments are closed.